Third Arch Investments is an investment firm that has been active in making investments in innovative companies, especially in the technology and healthcare sectors. With offices in Boston and San Francisco, Third Arch focuses on early and growth stage investments. In this article, we will provide an overview of Third Arch’s investment strategy, highlight some of their major deals, and discuss the industries and stages they target.
Third Arch Investments Focuses on Healthcare, Technology, and Consumer Products
Third Arch typically invests in healthcare, technology, and consumer products companies. Within healthcare, they look for biopharma, medical devices, diagnostics, and digital health companies. In technology, they target opportunities in SaaS, fintech, robotics, and semiconductors. For consumer products, Third Arch looks for disruptive and emerging brands.
Third Arch Participates in Early and Growth Stage Funding Rounds
As an early and growth stage investor, Third Arch looks for opportunities to invest in Seed, Series A, and Series B rounds. They occasionally invest in later stages as well. Their typical initial investment ranges from $500,000 to $10 million.
Notable Third Arch Investments Include Flex Pharma and Heartflow
Some of Third Arch’s most notable investments include Flex Pharma, a biotech company developing treatments for muscle cramps, and Heartflow, a digital health company with technology to model coronary anatomy. Third Arch has also invested in consumer brands like Bulletproof, Nutrabolt, and Hippeas.
In summary, Third Arch Investments is an active healthcare and technology focused investment firm targeting early and growth stage companies. Their focus areas include biotech, medtech, SaaS, and consumer products. Notable deals include Flex Pharma and Heartflow.